These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
398 related items for PubMed ID: 29169500
1. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass. Reijnen MMPJ, van Walraven LA, Fritschy WM, Lensvelt MMA, Zeebregts CJ, Lemson MS, Wikkeling ORM, Smeets L, Holewijn S. JACC Cardiovasc Interv; 2017 Nov 27; 10(22):2320-2331. PubMed ID: 29169500 [Abstract] [Full Text] [Related]
2. SUrgical versus PERcutaneous Bypass: SUPERB-trial; Heparin-bonded endoluminal versus surgical femoro-popliteal bypass: study protocol for a randomized controlled trial. Lensvelt MM, Holewijn S, Fritschy WM, Wikkeling OR, van Walraven LA, Wallis de Vries BM, Zeebregts CJ, Reijnen MM. Trials; 2011 Jul 18; 12():178. PubMed ID: 21767371 [Abstract] [Full Text] [Related]
3. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial. Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E, Beschorner U. J Endovasc Ther; 2014 Dec 18; 21(6):765-74. PubMed ID: 25453876 [Abstract] [Full Text] [Related]
4. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. Lumsden AB, Morrissey NJ, Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators. J Vasc Surg; 2015 Mar 18; 61(3):703-12.e1. PubMed ID: 25720929 [Abstract] [Full Text] [Related]
5. Midterm Results of a Japanese Prospective Multicenter Registry of Heparin-Bonded Expanded Polytetrafluoroethylene Grafts for Above-the-Knee Femoropopliteal Bypass. Shibutani S, Obara H, Matsubara K, Toya N, Isogai N, Ogino H, Watada S, Asami A, Kudo T, Kanaoka Y, Fujimura N, Harada H, Uchiyama H, Sato Y, Ohki T, Japanese Bypass Registry Group, Tokyo, Japan. Circ J; 2020 Feb 25; 84(3):501-508. PubMed ID: 32062636 [Abstract] [Full Text] [Related]
12. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study. Veraldi GF, Mezzetto L, Macrì M, Criscenti P, Corvasce A, Poli R. Ann Vasc Surg; 2018 Feb 25; 47():179-187. PubMed ID: 28943491 [Abstract] [Full Text] [Related]
13. The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery. Lensvelt MM, Wikkeling OR, Van Oostayen JA, Roukema JG, Zeebregts CJ, Reijnen MM. Vasc Endovascular Surg; 2012 May 25; 46(4):338-41. PubMed ID: 22504512 [Abstract] [Full Text] [Related]
19. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. Bosiers M, Deloose K, Verbist J, Schroë H, Lauwers G, Lansink W, Peeters P. J Vasc Surg; 2006 Feb 25; 43(2):313-8; discussion 318-9. PubMed ID: 16476607 [Abstract] [Full Text] [Related]
20. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency. Piazza M, Squizzato F, Lepidi S, Menegolo M, Grego F, Antonello M. Ann Vasc Surg; 2017 Oct 25; 44():282-288. PubMed ID: 28479462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]